Bell Investment Advisors’s IDEAYA Biosciences IDYA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$671 Hold
18
– – ﹤0.01% 1641
2026
Q1
$600 Hold
18
– – ﹤0.01% 1680
2025
Q4
$623 Sell
18
-14
-44% -$446 ﹤0.01% 1670
2025
Q3
$871 Hold
32
– – ﹤0.01% 1591
2025
Q2
$673 Sell
32
-26
-45% -$499 ﹤0.01% 1692
2025
Q1
$951 Buy
58
+26
+81% +$554 ﹤0.01% 1561
2024
Q4
$823 Sell
32
-19
-37% -$538 ﹤0.01% 1637
2024
Q3
$1.62K Hold
51
– – ﹤0.01% 1433
2024
Q2
$1.79K Buy
51
+18
+55% +$713 ﹤0.01% 1401
2024
Q1
$1.45K Buy
33
+14
+74% +$602 ﹤0.01% 1475
2023
Q4
$677 Hold
19
– – ﹤0.01% 1711
2023
Q3
$513 Buy
+19
New +$482 ﹤0.01% 1784

Other funds holding IDYA

Bell Investment Advisors's IDYA Position: Q2 2026 in Review

Bell Investment Advisors held its IDEAYA Biosciences (IDYA) position steady in Q2 2026 at 18 shares worth $671. The position accounts for ﹤0.01% of the portfolio, ranked #1641.

Bell Investment Advisors first reported a position in IDYA in Q3 2023 and has held it in 12 quarters since. The position peaked at $1.79K in Q2 2024. 285 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • Bell Investment Advisors held 18 shares of IDEAYA Biosciences worth $671 as of Q2 2026.
  • Bell Investment Advisors left its IDEAYA Biosciences share count unchanged in Q2 2026.
  • IDEAYA Biosciences made up ﹤0.01% of Bell Investment Advisors's portfolio in Q2 2026, its #1641 holding.
  • Bell Investment Advisors first reported a position in IDEAYA Biosciences in Q3 2023 and has held it in 12 quarters since.
  • Bell Investment Advisors's IDEAYA Biosciences position peaked at $1.79K in Q2 2024.
  • 285 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Bell Investment Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.